SEC EDGAR filings, ownership reports, and insider transactions for Bain Capital Life Sciences Opportunities IV, L.P..
Recent SEC filings for Bain Capital Life Sciences Opportunities IV, L.P. including SCHEDULE 13G/A, 13F-NT, 4 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 17 Feb 2026 | |||
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 17 Feb 2026 | 31 Dec 2025 | 028-26575 | |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 15 May 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 13 Jan 2025 | 08 Jan 2025 | 001-39712 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 13 Jan 2025 | 08 Jan 2025 | 001-39712 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 13 Jan 2025 | |||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 11 Dec 2024 |
Bain Capital Life Sciences Opportunities IV, L.P. files with the SEC under CIK 0002015553. This page aggregates EDGAR filings and related ownership activity.